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Background: Inflammatory bowel disease is an immunologically mediated disease. Notably, it is less common in
countries where there is a greater risk of exposure to helminths. In our study, we examined the modulatory effect
of the laminated layer extracted from the cyst wall of a helminth parasite, Echinococcus granulosus, on dextran
sulfate sodium (DSS)-induced colitis in mice.
Methods: An acute colitis was induced in BALB/c mice using 2.5% w/v DSS in drinking water. The crude extract of
E. granulosus laminated layer was injected intraperitoneally daily, starting 3 days before colitis induction. The Disease
Activity Index was monitored daily, colon length and weight were measured and histological scores were
evaluated. Nitric oxide (NO) and cytokine levels (interferon γ (IFN-γ), tumor necrosis factor α (TNF-α) and interleukin
10 (IL-10)) were assessed by enzyme-linked immunosorbent assay. In addition, the colonic expression of inducible
nitric oxide synthase (iNOS) and nuclear factor-κB (NF-κB) was examined. Statistical analyses were performed by
one-way analysis of variance and the survival rate was analyzed by the long rank test.
Results: Hydatid laminated layer pretreatment significantly improved the clinical symptoms and histological scores
(*** p < 0.01) observed during DSS-induced colitis and maintained mucus production by goblet cells. Furthermore,
treatment with hydatid laminated layer caused a significant decrease in NO, IFN-γ (** p < 0.01) and TNF-α production
(* p < 0.05) and an increase in IL-10 production. These results were associated with localized downregulation of iNOS
and NF-κB expression.
Conclusions: Our results demonstrate the potent anti-inflammatory effects of hydatid laminated layer. Furthermore,
preventive treatment with the laminated layer played a beneficial role in maintaining the integrity of the intestinal
mucosal barrier against DSS-induced injury.
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Inflammatory bowel disease (IBD), represented mainly
by ulcerative colitis and Crohn’s disease, is a chronic re-
lapsing inflammatory condition that mainly affects the
large and/or the small intestine. Its multi-factorial eti-
ology remains poorly understood but it is widely ac-
cepted that IBD results from an uncontrolled mucosal
immune response to intestinal microflora in genetically
susceptible hosts [1,2]. Dysfunction of the mucosal im-
mune response leads to infiltration of inflammatory cells
into the gut mucosa and concomitant production of
large amounts of proinflammatory cytokines including
interleukin 1β (IL-1ß), IL-6, interferon γ (IFN-γ), tumor
necrosis factor α (TNF-α) and nitric oxide (NO) [3]. The
pro-inflammatory cytokines IFN-γ and TNF-α are im-
portant inducers of inducible nitric oxide synthase
(iNOS) expression in macrophages, intestinal epithelial
cells and other cells [4].
Many authors have reported that high expression of
iNOS, a mediator of elevated NO production in inflamed
colonic mucosa, is strongly associated with the mucosal
lesions observed in both human IBD pathogenesis and
experimental colitis [4-9]. Moreover, the expression of
proinflammatory cytokines (IL-1ß, TNF-α, IL-6) and
iNOS are transcriptionally regulated by the transcription
factor nuclear factor (NF)-κB [4]. In addition to these
immunological factors, it has been reported that envir-
onmental factors strongly influence the onset of IBD.
Thus, IBD was initially described as pathologies affecting
mainly the industrialized countries. Currently, these
observations are no longer accurate considering the in-
creasing occurrence of IBD in developing countries.
These observations support the “hygiene hypothesis”,
which states that childhood exposure to helminths re-
duces the risk of developing IBD [10-12]. On the basis
of these observations, many studies have focused on the
protective and therapeutic effects of different helminth
species in experimental colitis. Indeed, infection of mice
with nematode helminths including Heligmosomoides
polygyrus, Trichinella spiralis, the trematode Schisto-
soma mansoni and the cestode Hymenolepis diminuta
demonstrated a protective effect against colitis in various
animal models [13-18]. Furthermore, these studies have
been extended to patients with IBD. Clinical trials
demonstrated that administration of eggs from the porcine
whipworm,Trichuris suis, to patients with IBD attenuated
the excessive intestinal inflammation [19-21].
Echinococcus granulosus is a helminth that causes a
cystic hydatid disease. Human cysts of E. granulosus are
mainly located in the lung or the liver [22]. The cyst
consists of a fluidfilled vesicle, containing two layers, a
germinal layer and an outer acellular laminated layer
(LL). The LL of E. granulosus is composed mainly of car-
bohydrates, proteins and lipids [23]. It appears to playtwo essential roles, as a mechanical barrier and an im-
munological barrier against the host immune defense. In
fact, the survival and persistence of the parasite in the
host involves evasion strategies that may be mediated by
the LL-induced inhibition of NO production [24-26]. In
our study, we investigated the potential protective effect of
the hydatid LL of E. granulosus in dextran sulfate sodium
(DSS)-induced experimental colitis. Here, we report that
pretreatment of colitic mice with the crude extract of LL
significantly reduced the severity of colitis, both macro-
scopically and histologically. Interestingly, this observation
correlated with a significant decrease in NO production
and proinflammatory cytokine (TNF-α, IFN-γ) secretion
and importantly an increase in the systemic IL-10 level.
Concomitantly, localized attenuation of iNOS and NF-κB
expression was evident in LL-pretreated mice.
Methods
Mice
Female BALB/c mice (8 weeks old) were purchased from
the Pasteur Institute (Algiers, Algeria). These mice were
acclimated for 1 week before the start of experiments
and kept under normal conditions with a 12 h dark/light
cycle with ad libitum access to food and water. Mice
ranging in weight from 20–22 g were divided into four
groups (n = 6–10 mice per group) as per Figure 1. This
study was approved by the ethics committee of the
national agency of research development in health
(ANDRS).
Initiation of acute DSS-induced colitis in mice
Mice were treated with 2.5% (w/v) DSS (MW 36 000–44
000; TdB Consultancy, Sweden) in their drinking water
ad libitum for 7 consecutive days as described by
Okayasu et al. [27] to induce acute colitis. Mice were
weighed every day during the experiment and their clinical
status, including weight loss, stool consistency and/or
diarrhea and presence of blood in stool, was monitored.
The Disease Activity Index (DAI) was determined as
described previously [18,28]. Briefly, a score from 0 to 4
was given for each parameter with a maximum DAI score
of 12, as follows: score 0 = no weight loss, normal stool, no
blood; score 1 = 1–3% weight loss; score 2 = 3–6% weight
loss, loose stool, presence of blood in stool; score 3 = 6–9%
weight loss; score 4 = >9% weight loss, diarrhea, presence
of fresh blood around the anus with extensive blood in
the stool.
Preparation of the crude extract of hydatid laminated
layer
Hydatid cysts from human lungs were obtained from the
Department of Thoracic Surgery, Mustapha Pacha Hos-
pital (Algiers, Algeria). Each patient gave written informed
consent for the study as required by the ethics committee
Figure 1 Experimental plan. Mice were randomly divided into five experimental groups (n = 6–10 per group). CTRL group received drinking
water only. DSS group received 2.5% (w/v) DSS in their drinking water ad libitum for 7 days to induce acute colitis. LL/DSS group were injected
daily with 200 μl LL by intra-peritoneal injection starting 3 days before and then concomitantly with DSS administration. LL group were injected
daily with 200 μl of LL by intra-peritoneal injection during the 10 days. PBS/DSS group were injected daily with 200 μl of PBS by intra-peritoneal
injection starting 3 days before and then concomitantly with DSS administration. The arrow shows the day when mice were euthanized.
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tract of LL was prepared as described previously by Steers
et al. [24]. Briefly, the hydatid cyst fluid was aseptically re-
moved by needle aspiration. Then, the hydatid cyst mem-
brane was washed several times in phosphate-buffered
saline (PBS) supplemented with 300 UI penicillin and
0.3 mg/ml streptomycin and frozen overnight to help the
removal of the LL. The latter was removed and sonicated
in PBS containing a cocktail of protease inhibitors (Invi-
trogen, Life Technologies, Carlsbad, CA, USA), for 10 s
per min on ice until a particulate solution was obtained.
Endotoxin contamination was removed using endotoxin
removing resin (Pierce Biotechnology, ThermoFisher
Scientific, Waltham, MA, USA). The absence of lipo-
polysaccharide in the crude extract was verified using
the Endosafe Limulus Amebocyte Lysate test (Charles
River Laboratories, Wilmington, MA, USA).
BALB/c mice were injected daily with 200 μl crude
extract of LL by intraperitoneal injection, starting 3 days
before and then concomitantly with DSS administration.
Plasma collection
Mice were anesthetized with chloroform, and blood was
collected via cardiac puncture. Blood was centrifuged to
isolate plasma, which was kept at-20°C until use.
Preparation of peritoneal macrophages and cell culture
Macrophages were obtained by peritoneal lavage of mice
using 5 ml of sterile PBS (pH = 7.4). Cellular suspensions
were washed three times with sterile PBS by centrifuga-
tion at 2800 rpm for 5 min, and then the pellets re-
suspended in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% heat inactivated fetal
bovine serum, 100 U/ml penicillin, 0.1 mg/ml strepto-
mycin and 20 mM L-glutamine. Cells were cultured at a
density of 4 × 105 cells/well in 24-well tissue culture plates.
After 2 hours, wells were washed using sterile PBS to re-
move non-adherent cells. Peritoneal macrophages (pMΦ)were incubated in complete DMEM at 37°C and 5% CO2
for 24 h. The cells used for all experiments were cultured
in triplicate. After 24 h, the supernatants were removed
and stored at-20°C for nitrite concentration measurement.
Nitrite concentration measurement
The Griess reaction was used to determine nitrite levels
as an indicator of NO production, in all culture superna-
tants and plasma, as described previously [29]. Briefly,
100 μl of each sample was mixed with 50 μl of Griess re-
agent (5% sulfanilamide, 0.5% napthylethylenediamine
dihydrochloride, 20% HCl). Samples were incubated at
room temperature for 20 min and the absorbance read
at 543 nm by spectrophotometer. The nitrite concentra-
tion was determined using a standard curve constructed
with sodium nitrite (NaNO2; 0–200 μmol/ml).
Measurement of systemic cytokine levels
Systemic levels of IFN-γ, TNF-α and IL-10 were deter-
mined in the plasma of mice using commercial enzyme-
linked immunosorbent assay (ELISA) kits according to
the manufacturer’s instructions (Invitrogen).
Assessment of colonic damage
After euthanasia, the colon was isolated and carefully
cleaned of mesentery tissue, vessels and fat, and the
length measured. A 4 cm segment of the distal colon
was removed and weighed after rinsing the lumen with
PBS. For the histological examination, 1 cm segments
from the distal colon were fixed in 10% formalin,
mounted in paraffin blocks and cut into 4-μm-thick
sections. The sections were stained with hematoxylin
and eosin (H & E) to study histological changes and with
the Alcian blue method to evaluate mucus secretion by
goblet cells. Sections were assessed in a blinded fashion as
previously described [18,30]. Briefly, a combined score of
inflammatory cell infiltration and tissue damage was deter-
mined as follows.
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in the lamina propria; score 1, increased infiltrate in the
lamina propria predominantly at the base of crypts;
score 2, confluence of inflammatory infiltrate extending
into the mucosa; score 3, transmural extension of
infiltrate.
Tissue damage: score 0, no mucosal damage; score 1,
< 50% loss of crypts in large areas; score 2, ≥ 50% loss
of crypts in large areas, epithelium intact; score 3,
total loss of crypts in large areas and epithelium loss.
Investigation of NF-κB and iNOS expression by
immunofluorescence
An immunofluorescence study of NF-κB and iNOS ex-
pression was performed on formalin-fixed, paraffin-
embedded samples. Sections of 3-μm-thick tissue were
deparaffinized using xylene solvent, and rehydrated
through a graded series of ethanol. The sections were
then subjected to antigen retrieval in citrate buffer at
pH 6.0, 95°C for 45 min. Sections were blocked for 2 h
with 5% skim milk in PBS, then incubated with rabbit
monoclonal antibodies against mouse NF-κB p65 subunit
and iNOS (Santa Cruz Biotechnology, Dallas, TX, USA;
diluted 1:100) overnight at 4°C. Finally, sections were
labelled with anti-rabbit IgG-FITC (Life Technologies,
diluted 1:1000) for 1 hour. Sections were washed three
times with PBS between each step. Slides were covered
with Kaiser’s glycerin-PBS and examined using a Zeiss
inverted fluorescence microscope (Zeiss, Oberkochen,
Germany). Pictures were taken using a digital camera at ×
40 magnification.
Statistical analysis
All data are expressed as the means ± standard error of the
mean (SEM). Statistical analyses were performed by one-
way analysis of variance to compare both time (days of
DSS) and treatment effects. Probability values of p < 0.05
were considered to be statistically significant.
Results
Preventive treatment with hydatid LL ameliorates clinical
symptoms of DSS-induced colitis
After administration of 2.5% DSS to mice in their drink-
ing water, all animals developed symptoms of colitis in-
cluding progressive weight loss, diarrhea and gross rectal
bleeding from days 4 to 5 after the start of DSS adminis-
tration. These symptoms were more marked at the end
of the experimental period, when animals showed mul-
tiple clinical signs of severe disease, including marked
weight loss and moribund state. Of the 10 mice in the
DSS group, three died between days 5 and 7 (Figure 2).
However, pretreatment with hydatid laminated layer
(LL/DSS) significantly reduced the clinical score (DAI)
in comparison with the DSS group. Furthermore, nomoribund symptoms or mortality occurred in the LL/
DSS group (Figure 2).
Pretreatment with hydatid LL attenuates histological
alterations in DSS-induced colitis
Shortening of the colon is used as a marker of inflam-
mation in the DSS-induced colitis model. In the DSS-
alone group the length of the colon was significantly
shortened (4.6 ± 0.40 cm, **** p < 0.0001) compared with
the control untreated group (7.95 ± 0.76 cm), whereas
in the DSS/LL group the pretreatment with LL pre-
vented the colonic shortening (6.3 ± 0.58 cm, *** p <
0.001, Figure 3A and B). No significant difference was
observed between the LL alone group and the un-
treated control group (Figure 3A).
The histological analysis of the distal colon of DSS
treated mice revealed marked mucosal damage, character-
ized by an intense inflammatory cell infiltrate extending
throughout the mucosa and submucosa, crypt destruc-
tion, total depletion of goblet cells and mucosa erosion
(Figure 3E). However, in the LL/DSS group, LL pre-
treatment significantly decreased the histological score
compared with the DSS group (*** p <0.001, Figure 3D).
The tissue alterations were also markedly reduced in
LL/DSS group, with less cellular infiltration into the
mucosa, more intact epithelium structure and normal
crypts observed in the majority of mice of this group
(Figure 3E). The untreated control group showed normal
colonic mucosa and submucosa (Figure 3E) and mice
from LL alone group displayed the same histological
structure.
Furthermore, histological analysis using Alcian blue
staining showed enhanced mucus production in LL/DSS
mice compared with the DSS group, where a total deple-
tion of goblet cells was observed (Figure 4A). Higher
numbers of goblet cells associated with mucus secretion
were found in the LL/DSS group in comparison with the
DSS group (p < 0.001, Figure 4A, B). The mice from the
LL alone group displayed the same structure observed in
control mice, with numerous goblet cells accompanied
by mucus secretion observed in both these groups
(Figure 4).
Pretreatment with hydatid LL reduces systemic levels of
NO in DSS-induced colitis
NO is an important mediator of immune and inflamma-
tory responses. It has been shown previously that NO is
highly implicated in intestinal inflammation during IBD
and experimental colitis [4-9]. In our current study, we
focused our attention on investigating the effect of the
crude extract of hydatid LL on NO production in DSS-
induced colitis in mice.
NO measurement in the plasma of mice showed high
systemic levels of NO in mice from the DSS group
Figure 2 Pretreatment with hydatid ameliorates clinical symptoms of DSS-induced colitis. BALB/c mice were pretreated with the crude
extract of LL starting 3 days before and then concomitantly with DSS administration. A, Weight loss, stool consistency, and fecal blood were
scored to provide the DAI for each group. B, Survival rate of mice during the experiment. C, Percent change from original body weight in all
groups. Data are shown for six to ten mice per group.
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4.40 ± 1.48 cm, *** p < 0.001). However, pretreatment of
mice with hydatid LL caused a significant decrease in
systemic NO levels in comparison with mice treated
with DSS alone (*** p < 0.001, Figure 5A). Moreover,
there was no significant difference in NO levels in
plasma of mice from the LL/DSS group and the un-
treated control group (p > 0.05, Figure 5A).Crude extract of hydatid LL reduces nitrite level in
peritoneal macrophage cultures
The nitrite level produced by cultured pMΦ was mea-
sured. Nitrite production by cultures of pMΦ obtained
from colitic mice was significantly increased compared
with pMΦ from untreated control mice (**** p < 0.0001,
Figure 5B). Interestingly, NO concentration in pMΦ su-
pernatants was lower from hydatid LL pretreated mice,
compared with all other experimental groups (**** p <
0.0001 DSS group versus LL/DSS group, ** p < 0.01 LL/
DSS group versus untreated control group). Conversely,
animals given hydatid LL without DSS consumption
showed no difference in nitrite levels in comparison with
the control group (Figure 5B).Changes in cytokine levels in vivo
To analyze the effect of the hydatid LL on cytokine pro-
duction in vivo during DSS-induced colitis, we measured
the levels of proinflammatory cytokines (TNF-α, IFN-γ)
and the immunoregulatory cytokine IL-10 by ELISA in
plasma from mice (Figure 6). Systemic IFN-γ and TNF-α
levels were markedly increased in the DSS group in com-
parison with controls (p < 0.01). Hydatid LL pretreatment
significantly attenuated both IFN-γ and TNF-α expression
compared with mice treated with DSS alone (** p < 0.01,
* p < 0.05 respectively). However, treatment of control
mice with LL alone also induced an increase in plasma
IFN-γ and TNF-α level, although without any significant
effect on overall health compared with the control group
(Figure 6). The systemic levels of IL-10 were increased in
the LL/DSS group in comparison with the DSS group,
although no statistically significant differences were ob-
served among the groups (Figure 6C).
Down-regulation of iNOS and NF-κB expression in colonic
tissue of mice pretreated with crude extract of hydatid LL
High expression of iNOS is considered the most import-
ant source of elevated nitrite levels in experimental colitis


















Figure 3 Pretreatment with hydatid LL protects BALB/c mice from DSS-induced colitis. A and B, On day 7, the colon of each mouse was
removed and the length was measured; B, Representative photomicrographs of colons are shown. C, The colon of each mouse was weighed and
the weight indicated is for 1 cm length of the colon. D, Histological scores for colon cellular infiltration and tissue alterations. All results are
expressed as the mean ± standard error of mean. p values from LSD post-hoc ANOVA test are indicated (**p < 0.01, ***p < 0.001, ****p < 0.0001).
The results are shown for 6 to 10 mice per group. E, Representative photomicrographs (×20, ×40) of H & E stained colon tissue from each group;
(a, b) CTRL group, (c, d) DSS group, (e, f) LL + DSS group. M: Mucosa, SM: Submucosa. Red arrow: eroded mucosa, dark arrow: cell infiltrate
extending throughout the mucosa and the submucosa, yellow arrow: epithelium intact, star: crypt destruction.
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Figure 4 Pretreatment with hydatid LL protects colonic goblet cells in DSS-induced colitis. A, Representative photomicrographs of Alcian
blue stained colonic tissue. (a) CTRL group: normal crypts and important mucus secretion, (b) DSS group: total depletion of goblet cells
accompanied by the absence of mucus, (c) LL + DSS group: normal crypts and secretion of mucus by the goblet cells. (d) LL group: normal
crypts, presence of a number of goblet cells secreting mucus. B, Changes in goblet cells number. All results are expressed as the mean ± standard
error of the mean. p values from LSD post-hoc ANOVA test are indicated (***p < 0.001, ****p < 0.0001). GC: Goblet Cells.
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ined the effect of crude extract of hydatid LL on iNOS
and NF-κB expression in DSS-induced colitis in mice.
Colon tissue sections were tested for the expression of
iNOS and NF-κB by immunofluorescence using anti-
iNOS and anti-NF-κB p65 subunit antibodies. The expres-
sion of both NF-κB and iNOS was markedly increased in
the colonic mucosa of DSS treated mice in comparison
with the untreated control group. This increase in expres-
sion in colonic mucosa was significantly attenuated by LL
treatment (Figure 7).
Discussion
IBD is characterized by disruption of the intestinal
microbiota that leads to an excessive inflammatory
response in the gut. Currently, modulation of intestinal
inflammation using helminths is being explored as a
promising prophylactic and therapeutic approach for
IBD. Several experimental studies using different animal
models of colitis have shown the ability of parasitic
worms to attenuate intestinal inflammation. Further-
more, intestinal parasitic worms such as T. suis have
been shown to have a therapeutic effect in patients withFigure 5 LL pre-treatment reduces the production of nitric oxide in p
supernatant of peritoneal macrophage cultures (B). All results are expr
LSD post-hoc ANOVA test are indicated (***p < 0.001, ****p < 0.0001).ulcerative colitis and Crohn’s disease [19-21]. The data
presented here demonstrate that the pretreatment of
mice with hydatid LL extracted from the cyst of the ces-
tode parasite E. granulosus attenuates inflammation in a
DSS-induced colitis model in mice.
The oral administration of 2.5% DSS in mice causes
acute colitis. Animals from this group showed a variety
of clinical symptoms of IBD including diarrhea, bloody
stool and weight loss. A Disease Activity Index score
was used as a reliable tool to assess the extent of the
gastrointestinal disease in the DSS-induced experimental
colitis. At the end of the experimental period, the clin-
ical symptoms were more pronounced. Our observations
are in agreement with those reported in other studies
using the DSS-induced colitis model [27,28]. However,
pretreatment of mice with hydatid LL significantly im-
proved the clinical score, suggesting a protective effect
of hydatid LL in this model of colitis. The histological
scores indicate that pretreatment of mice with LL pre-
vented mucosal damage characterized by loss of crypt
glands and epithelium destruction and inhibited colon
shortening as observed in the DSS-alone group. Moreover,
a histological study using Alcian blue staining showedlasma (A) in DSS-induced colitis in BALB/c mice and in the
essed as the means ± SEM for 5 to 10 mice per group. P values from
Figure 6 Effect of crude extract of LL on cytokines in DSS-induced colitis. IFN-γ (A), TNF-α (B) and IL-10 (C) concentration in the plasma of
mice from all groups. LL-pretreatment reduces the systemic levels of IFN-γ and TNF-α and increased IL-10 systemic levels. All results are expressed
as the mean ± standard error of the mean. p values from LSD post-hoc ANOVA test are indicated (*p < 0.05, **p < 0.01). Abbreviations: IFN-γ,
interferon-γ; TNF-α, tumor necrosis factor α; IL-10, interleukin 10.
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secreting mucus in the LL/DSS group, in stark contrast to
the DSS treated mice. This observation suggests that LL
pretreatment may protect mice from DSS-induced colitis
by promoting mucus secretion.
IBD and DSS induced colitis are characterized by ele-
vated levels of proinflammatory cytokines including IFN-γ,
TNF-α and IL-6, and also increased NO production [7,8],
which contribute to the destruction of the epithelium,
ulceration of the intestinal mucosa, erosion and infiltration
of inflammatory cells [27,30,31]. We focused our attention
on the effect of LL pretreatment on NO production and
TNF-α, IFN-γ secretion knowing that these cytokines are
potent inducers of iNOS expression [4,32]. Our data dem-
onstrate an increase in NO levels both in plasma andmacrophage culture supernatants of mice from the DSS
group. Our results are in line with previous studies show-
ing that intestinal inflammation observed in IBD and
DSS-induced colitis is associated with prolonged iNOS
activation and increased NO production [4,6,32]. In fact,
NO contributes to the perpetuation of inflammation,
causing increased tissue damage [33].
Many authors have reported the synergistic effect of
IFN-γ/TNF-α on iNOS induction through NF-κB activa-
tion [34,35]. Notably, NF-κB activity is enhanced in the
intestinal mucosa of both patients with IBD and the
DSS-induced colitis model [4,36]. In our study, we re-
ported that an elevated level of NO was associated with
an increased systemic level of IFN-γ and TNF-α, and
over expression of iNOS and NF-κB in colonic tissue.
AB
Figure 7 (See legend on next page.)
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Figure 7 Representative images of immunofluorescence staining. Distal colon tissues from mice were stained with anti-iNOS (a–d) and anti
p65 NF-κB subunit (e–h). Colonic tissue stained with anti-iNOS (a) CTRL group, (b) DSS group, (c) LL/DSS group, (d) LL group. Colonic tissue
stained with anti-p65 subunit NF-κB (e) CTRL group, (f) DSS group, (g) LL/DSS group, (h) LL group. Red arrow indicates iNOS or NF-κB staining,
all magnifications are × 40.
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decrease in NO production, in both plasma and pMΦ
culture supernatants, compared with mice from the DSS
group. Moreover, pretreatment of mice with hydatid LL
induced a concomitant decrease of IFN-γ and TNF-α
levels in plasma and the attenuation of iNOS and NF-κB
expression in the mucosa. Moreover, other studies have
described an important immunomodulatory role for
hydatid LL through the downregulation of NO production
in mice in vivo and in vitro [24,25].
However, administration of hydatid LL alone to BALB/c
mice also induced an increase in plasma TNF-α and IFN-γ
levels, although without any significant effect on mouse
health. This result is probably related to the heterogeneous
mix of compounds present in the crude extract of the
hydatid LL, which may induce immune responses in
healthy mice. Hence, identification and purification of the
bioactive molecule (s) should provide more potent and
effective anti-inflammatory effects. Therefore, our future
aim will be to characterize the bioactive molecules within
the LL extracted from the cyst wall of E. granulosus.
The hydatid LL is a crucial element of the host-parasite
interface. It represents an important barrier against im-
munological host responses [26,37]. To survive, the para-
site impairs Th1 protective responses and induces Th2
and regulatory T cell (Treg) responses, which are then in-
volved in the mechanism of the immune evasion strategy.
This effect may be mediated by LL antigens [26,37]. Many
reports suggest the ability of helminths to down-regulate
the proinflammatory immune response via the induction
of Tregs or the production of antiinflammatory cytokines,
for example IL-10 and tumor growth factor β, which can
regulate both Th1 and Th2 responses [38]. Thus, the
decrease of NO and proinflammatory cytokine levels in
plasma of pretreated mice LL is likely related to the im-
munomodulatory effect of the cystic extract. It appears
that this effect may be mediated by the immunoregulatory
action of IL-10, as this cytokine was highly increased
during treatment with the cystic extract (Figure 6). It
has been reported that IL-10 inhibits proinflammatory
cytokine production, including IFN-γ, IL-1ß, TNF-α
and IL-12, leading to the inhibition of iNOS expression.
It has also been suggested that IL-10 may exert its
regulatory functions through NF-κB inhibition [36].
Conclusions
Collectively, the results obtained are in favor of the
hygiene hypothesis and suggest the existence of animmunoprotective effect mediated by helminths against
colitis. In our model, this effect appears to be related to
the action of larval structures during echinococcosis
evolution. This beneficial effect of the hydatid LL could
represent a promising therapeutic approach. However, fur-
ther investigations are required to fully explore the safety
aspects and elucidate the exact mechanism of action.
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